Investor Ideas #Potcasts; #Cannabis News
and Stocks on the Move; (TSXV: $HVT.V),
(CSE: $HUGE.C), (TSXV: $N.V), (TSXV: $POCM.V), (CSE: $MMEN.C, OTCQB: $MMNFF)
Pt. Roberts, WA; Delta, BC – June 18,
2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of
its new series, Investorideas.com potcastsCM - cannabis news and stocks to
watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/06181Potcasts-TSXVHVTNPOCMCSEHUGEMMEN.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast; looking at cannabis news, stocks to watch as
well as insights from thought leaders and experts. Today’s podcast features
news from Harvest One Cannabis Inc. traded on the
TSX-Venture as HVT, FSD Pharma Inc. trading on the CSE as HUGE, Namaste
Technologies Inc. trading on the TSX-Venture as N, POCML 4 Inc. trading on the
TSX-Venture as POCM and MedMen Enterprises Inc. trading on the CSE as MMEN and
OTCQB as MMNFF.
Harvest One
Cannabis Inc. announced that its wholly owned subsidiary, United Greeneries,
has received a Dealer's License pursuant to the Controlled Drugs and Substances
Act under Health Canada.
The license
now allows UG to import narcotics into Canada, including its signature Gelpell
Microgel CBD capsules that are produced in Switzerland and that are already
sold as a nutritional supplement in the European Union and as a prescription
drug in Australia.
The Dealer's
License will also further allow the Company to export its medical cannabis
products to other markets with favourable medical marijuana regulations,
including Germany.
As well, the
Company will further engage in research and development of cannabis infused
products and is preparing a state-of-the art product development centre at its
Duncan facility in British Columbia, planning to soon offer several value-add
services to the industry, including a full quality control laboratory and
co-packaging.
FSD Pharma
Inc. has been added to the CSE 25 Composite Index, effective after the close on
Friday, June 15, 2018. The Company met index entry requirements and bypassed
the typical seasoning period for a new entrant due to its placement in the top
quartile of the Index. The Company is pleased to see FSD recognized so quickly
as a "cream of the crop" new entrant on the Index.
FSD Pharma,
owns, through its wholly-owned subsidiary FV Pharma Inc., a license to produce
marijuana under the Access to Cannabis for Medical Purposes Regulations (ACMPR)
which was originally granted on October 13, 2017. Headquartered at the former
Kraft plant in Cobourg, Ontario, approximately an hour's drive from Toronto,
FSD Pharma's management's mission is to transform the facility into the largest
hydroponic indoor cannabis facility in the world.
Namaste
Technologies Inc. announced that further to its January 18th, 2018
letter of intent, that the Company has signed a subscription agreement to
acquire 10% of the issued share capital of Israeli licensed producer of medical
cannabis, Cannbit Ltd for NIS 2,500,000 or approximately CAD $908,000, which
includes a combination of both cash and shares.
Cannbit has
also signed a binding agreement to complete a merger with a company listed on
the Tel Aviv stock exchange, whereby Cannbit will retain 85% ownership of the
combined public entity. This is expected to increase Cannbit’s value
significantly higher than what Namaste acquired its 10% equity stake for. In
anticipation of closing this transaction, Namaste has established a supply
arrangement with Cannbit to export cannabis to the Canadian market (subject to
approval by Health Canada and the Israeli government) and will also engage with
Cannbit to expand the Company's Israeli-based vaporizer sales platform.
POCML 4 Inc.
announced that MediPharm Labs Inc. has commenced the construction of its
world-class extraction facility in Australia, through its subsidiary MediPharm
Labs Australia Pty. Ltd. MediPharm has signed a binding letter agreement with
POCML which outlines the general terms and conditions pursuant to which POCML
and MediPharm have agreed to complete a transaction that will result in a
reverse take-over of POCML by the shareholders of MediPharm. For further
information regarding the Transaction, please refer to the press release of
POCML dated May 15, 2018 available on SEDAR at www.sedar.com.
Finally
looking at MedMen Enterprises Inc. who announced today that the OTC Markets
Group has approved the listing of the Company’s subordinate voting shares on
its OTCQB Venture Market under the ticker symbol “MMNFF”. MedMen’s subordinate
voting shares began trading on the OTCQB at the opening of the market today.
The Company’s subordinate voting shares continue to be listed on the Canadian
Stock Exchange (CSE) under the ticker symbol "MMEN". MedMen’s
subordinate voting shares are also eligible to be deposited into the Depository
Trust Company (DTC), one of the world’s largest securities depositories and electronic
clearing and settlement service provider, for its common shares trading under
OTC.
"With
our subordinate voting shares now trading on the OTC, U.S. investors can more
easily access one of the leading cannabis companies in the country with assets
in the top strategic markets: California, Nevada, and New York,” said Adam
Bierman, MedMen’s co-founder and chief executive
Investor ideas reminds all listeners to read
our disclaimers and disclosures on the Investorideas.com website and this
podcast is not an endorsement to buy products or services or securities.
Investors are reminded all investment involves risk and possible loss of
investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock
directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis
Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
To sponsor this podcast or be a guest
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment